This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Katja Zimmerman: Innovator in Medicinal Chemistry
Introduction
Katja Zimmerman is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. Her work focuses on creating innovative solutions for the treatment and prevention of various diseases.
Latest Patents
Katja Zimmerman holds a patent for "Substituted azabicyclic compounds and the use thereof." This patent relates to novel substituted pyrrolopyridine, pyrazolopyridine, and isoxazolopyridine derivatives. The application outlines processes for their preparation and their use in treating and preventing diseases, with a particular emphasis on cardiovascular disorders. She has 1 patent to her name.
Career Highlights
Katja Zimmerman is associated with Bayer Intellectual Property GmbH, where she applies her expertise in medicinal chemistry. Her role involves researching and developing new compounds that can lead to effective treatments for various health conditions.
Collaborations
Throughout her career, Katja has collaborated with notable colleagues, including Barbara Albrecht-Küpper and Frank Süßmeier. These collaborations have enhanced her research and contributed to the advancement of her projects.
Conclusion
Katja Zimmerman's innovative work in the field of medicinal chemistry exemplifies her commitment to improving healthcare through scientific advancements. Her contributions are paving the way for new treatments that can significantly impact patient outcomes.